| 1. |
Shirodkar AR, Pathengay A, Flynn HW Jr, et al. Delayed-versus acute-onset endophthalmitis after cataract surgery[J]. Am J Ophthalmol, 2012, 153(3): 391-398. DOI: 10.1016/j.ajo.2011.08.029.
|
| 2. |
Al-Mezaine HS, Al-Assiri A, Al-Rajhi AA. Incidence, clinical features, causative organisms, and visual outcomes of delayed-onset pseudophakic endophthalmitis[J]. Eur J Ophthalmol, 2009, 19(5): 804-811. DOI: 10.1177/112067210901900519.
|
| 3. |
王國峰, 魏六峰. 白內障術后遲發性真菌性眼內炎一例[J]. 中華眼外傷職業眼病雜志, 2011, 33(12): 958. DOI: 10.3760/cma.j.issn.2095-1477.2011.12.031.Wang GF, Wei LF. A case of delayed fungal endophthalmitis after cataract surgery[J]. Chin J Ocul Traum Occupat Eye Dis, 2011, 33(12): 958. DOI: 10.3760/cma.j.issn.2095-1477.2011.12.031.
|
| 4. |
郭艷陽, 高繼鑫, 海璐明, 等. 鏈格孢霉致播散型皮膚鏈格孢病3例臨床分析[J]. 中華皮膚科雜志, 2022, 55(11): 996-999. DOI: 10.35541/cjd.20210718.Guo YY, Gao JX, Hai LM, et al. Clinical analysis of three cases of disseminated cutaneous alternariosis caused by Alternaria[J]. Chin J Dermetol, 2022, 55(11): 996-999. DOI: 10.35541/cjd.20210718.
|
| 5. |
何鍵, 程鈞, 董燕玲, 等. 真菌性角膜炎1414例臨床分析[J]. 中華眼科雜志, 2020, 56(4): 286-293. DOI: 10.3760/cma.j.cn112142-20190618-00320.He J, Cheng J, Dong YL, et al. A clinical analysis of 1 414 cases of fungal keratitis[J]. Chin J Ophthalmol, 2020, 56(4): 286-293. DOI: 10.3760/cma.j.cn112142-20190618-00320.
|
| 6. |
王麗婭, 許中中, 張俊杰, 等. 局部應用伏立康唑治療真菌性角膜炎的臨床觀察[J]. 中華眼科雜志, 2016, 52(9): 657-662. DOI: 10.3760/cma.j.issn.0412-4081.2016.09.005.Wang LY, Xu ZZ, Zhang JJ, et al. Topical voriconazole as an effective treatment for fungal keratitis[J]. Chin J Ophthalmol, 2016, 52(9): 657-662. DOI: 10.3760/cma.j.issn.0412-4081.2016.09.005.
|
| 7. |
孫聲桃, 王麗婭, 徐筠, 等. 互隔交鏈孢霉菌性角膜炎的臨床與病原學研究[J]. 中華眼科雜志, 2007, 43(1): 32-35. DOI: 10.3760/j:issn:0412-4081.2007.01.010.Sun ST, Wang LY, Xu J, et al. The clinical and pathogenic characteristics of keratitis caused by Alternaria alternata[J]. Chin J Ophthalmol, 2007, 43(1): 32-35. DOI: 10.3760/j:issn:0412-4081.2007.01.010.
|
| 8. |
Pérez-Cantero A, López-Fernández L, Guarro J, et al. Azole resistance mechanisms in Aspergillus: update and recent advances[J/OL]. Int J Antimicrob Agents, 2020, 55(1): 105807[2019-09-19]. https://pubmed.ncbi.nlm.nih.gov/31542320/. DOI: 10.1016/j.ijantimicag.2019.09.011.
|
| 9. |
Rummelt V, Ruprecht KW, Boltze HJ, et al. Chronic Alternaria alternata endophthalmitis following intraocular lens implantation[J]. Arch Ophthalmol, 1991, 109(2): 178. DOI: 10.1001/archopht.1991.01080020024014.
|
| 10. |
Stem MS, Todorich B, Yonekawa Y, et al. Incidence and visual outcomes of culture-proven endophthalmitis following dexamethasone intravitreal implant[J]. JAMA Ophthalmol, 2017, 135(4): 379-382. DOI: 10.1001/jamaophthalmol.2016.5883.
|
| 11. |
Boyer DS, Yoon YH, Belfort R Jr, et al. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema[J]. Ophthalmology, 2014, 121(10): 1904-1914. DOI: 10.1016/j.ophtha.2014.04.024.
|
| 12. |
Cruz-I?igo YJ, Klein K, Reddy RK. Case report of abiotrophia deffctiva endophthalmitis after repeated injections of Dexamethasone intravitreal implant (OZURDEX)[J]. Retin Cases Brief Rep, 2022, 16(2): 170-173. DOI: 10.1097/ICB.0000000000000925.
|
| 13. |
王倩, 原公強, 張靜靜. 玻璃體腔注射Ozurdex術后感染性眼內炎2例[J]. 臨床眼科雜志, 2024, 32(1): 76-77. DOI: 10.3969/j.issn.1006-8422.2024.01.019.Wang Q, Yuan GQ, Zhang JJ. 2 cases of infective endophthalmitis after intravitreal injection of Ozurdex[J]. J Clin Ophthalmol, 2024, 32(1): 76-77. DOI: 10.3969/j.issn.1006-8422.2024.01.019.
|
